Product Information
- 5,12-Naphthacenedione, 7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxyethyl)-, [7S-[7α,9α,9(R*)]]-
- 5,12-Naphthacenedione, 7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-, (7S,9S)-
- 4-Demethoxydaunorubicinol
- (7S,9S)-7-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-5,12-naphthacenedione
- Antibiotic FCE 22723
Idarubicinol is an analog of the anticancer drug idarubicin and is known for its potent apoptotic effects on cancer cells. It works by inhibiting protein kinases, which are enzymes that play a crucial role in cancer cell growth and division. Idarubicinol has been shown to be effective against a wide range of human cancers, including Chinese hamster ovary (CHO) tumors. This medicinal compound has been identified in urine samples from patients undergoing chemotherapy with idarubicin, indicating that it may play a role in the treatment of cancer. As an inhibitor of kinases, Idarubicinol has potential as a therapeutic agent for the treatment of various types of cancer.
Chemical properties
Technical inquiry about: 3D-LDA18966 Idarubicinol
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
